International Journal of Environmental Research and Public Health | |
Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic | |
Jonathan Cortés-Martín1  Raquel Rodríguez-Blanque2  JuanCarlos Sánchez-García3  AnaEugenia Marín-Jiménez4  Maria Montiel-Troya5  Lourdes Díaz-Rodríguez6  | |
[1] Research Group CTS 1068, Andalusia Research Plan, Junta de Andalucía, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain;Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, Distrito Sanitario Granada-Metropolitano, 18013 Granada, Spain;Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, JMADOC, School of Nursing, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain;Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, Quantitative Methods for the Economics and Enterprise, Faculty of Economics and Business Sciences, University of Granada, 18071 Granada, Spain;Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, School of Nursing Ceuta Campus, Faculty of Health Sciences, University of Granada, 51001 Ceuta, Spain;Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, School of Nursing, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain; | |
关键词: rare disease; depression; anxiety; COVID-19; SARS CoV-2; pandemic; | |
DOI : 10.3390/ijerph18063234 | |
来源: DOAJ |
【 摘 要 】
Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group.
【 授权许可】
Unknown